Press Releases

All Releases
View Summary Ironwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call
Jul 21, 2016
PDF 13.1 KB Add to Briefcase
View Summary Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review
Jun 9, 2016
PDF 601.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
Jun 6, 2016
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad
Jun 3, 2016
PDF 20.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference
Jun 1, 2016
PDF 12.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference
May 18, 2016
PDF 9.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week® 2016
May 17, 2016
PDF 333.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
May 9, 2016
PDF 98.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference
May 3, 2016
PDF 12.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad
Apr 26, 2016
PDF 296.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call
Apr 25, 2016
PDF 13.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors
Apr 7, 2016
PDF 14.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis
Apr 5, 2016
PDF 282.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences
Mar 30, 2016
PDF 283.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease
Mar 23, 2016
PDF 16.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 9, 2016
PDF 12.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference
Mar 1, 2016
PDF 12.7 KB Add to Briefcase
View Summary Video Alert: Updated 2016 Direct-to-Consumer Awareness Campaign Available for LINZESS® (linaclotide)
Feb 29, 2016
PDF 12.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Filing by Astellas of New Drug Application in Japan with Linaclotide for the Treatment of Adults with IBS-C
Feb 24, 2016
PDF 283.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update
Feb 18, 2016
PDF 99.8 KB Add to Briefcase
Showing 41-60 of 241 Page: 1 2 3 4 5 6 7 ... 13  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.